Live
- Donald Trump Effect: Gold Prices Drop Sharply in a Single Day
- Australian govt to ban social media access for children younger than 16
- ED conducts raids on multiple sellers linked to e-com players including Amazon, Flipkart
- India A vs Australia A: Contrasting outings for KL Rahul and Dhruv Jurel at Melbourne
- Lakshya and Ananya Panday Pair Up in Dharma Productions' Next Big Film
- After political furore, BJP leader withdraws slur on Sharad Pawar
- Kerala Cong cries foul over police raid on hotel rooms of women leaders, moves ECI
- Sara Ali Khan and Sidharth Malhotra Team Up for New Film by ‘Panchayat’ Director
- Mount Marapi in Indonesia's West Sumatra erupts
- Telangana woman kidnapped after son doesn't return to work in Maha farms
Dr Reddy's launches skin treatment drug in US
Highlights
Dr Reddy's Laboratories on Wednesday said it launched Daptomycin for injection, used for treating complicated skin infections, in the US market.
New Delhi: Dr Reddy's Laboratories on Wednesday said it launched Daptomycin for injection, used for treating complicated skin infections, in the US market.
The company launched its product, which is generic version of Merck Sharp & Dohme Corp's Cubicin, after obtaining approval from the US Food and Drug Administration (USFDA), the pharma major said.
According to IQVIA Health, the Cubicin for injection (daptomycin for injection) brand and generics had sales of around $640.8 million for the most recent 12 months ending in March 2019.
Next Story
ADVERTISEMENT
